 | • レポートコード：MRC-IM30422 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の調査レポートによると、世界の静脈内（IV）イブプロフェン市場規模は2021年に58億ドルに達しました。今後、2027年には94.8億ドルになり、2022年から2022年の間に年平均8.10％成長すると予測しています。本調査レポートでは、静脈内（IV）イブプロフェンの世界市場について調査・分析を行い、序論、調査範囲・手法、エグゼクティブサマリー、イントロダクション、製品用量別（100mg、200mg、400Mg、800Mg）分析、疾患別（痛み/炎症、発熱）分析、年齢別（小児、大人）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを掲載しています。なお、企業情報には、Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.などが含まれています。 ・序論 ・調査範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界の静脈内（IV）イブプロフェン市場規模：製品用量別 - 100mg静脈内（IV）イブプロフェンの市場規模 - 200mg静脈内（IV）イブプロフェンの市場規模 - 400mg静脈内（IV）イブプロフェンの市場規模 - 800mg静脈内（IV）イブプロフェンの市場規模 ・世界の静脈内（IV）イブプロフェン市場規模：疾患別 - 痛み/炎症における市場規模 - 発熱における市場規模 ・世界の静脈内（IV）イブプロフェン市場規模：年齢別 - 小児における市場規模 - 大人における市場規模 ・世界の静脈内（IV）イブプロフェン市場規模：地域別 - 北米の静脈内（IV）イブプロフェン市場規模 - アジアの静脈内（IV）イブプロフェン市場規模 - 欧州の静脈内（IV）イブプロフェン市場規模 - 中南米の静脈内（IV）イブプロフェン市場規模 - 中東・アフリカの静脈内（IV）イブプロフェン市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global intravenous (IV) ibuprofen market size reached US$ 5.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.48 Billion by 2027, exhibiting a growth rate (CAGR) of 8.10% during 2022-2027.
Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body’s production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.
Intravenous (IV) Ibuprofen Market Trends:
The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor. Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth. Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous (IV) ibuprofen market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product dose, indication and age group.
Breakup by Product Dose:
100 Mg Dose
200 Mg Dose
400 Mg Dose
800 Mg Dose
Breakup by Indication:
Pain/Inflammatory
Fever
Breakup by Age Group:
Pediatrics
Adults
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.
Key Questions Answered in This Report:
How has the global intravenous (IV) ibuprofen market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global intravenous (IV) ibuprofen market?
What are the key regional markets?
What is the breakup of the market based on the product dose?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the age group?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global intravenous (IV) ibuprofen market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Intravenous (IV) Ibuprofen Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Dose
6.1 100 Mg Dose
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 200 Mg Dose
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 400 Mg Dose
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 800 Mg Dose
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Indication
7.1 Pain/Inflammatory
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Fever
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Age Group
8.1 Pediatrics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Adults
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Cumberland Pharmaceuticals Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Hyloris Pharmaceuticals SA
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Recordati Rare Diseases Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 VALMOR Laboratories CA
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Xgen Pharmaceuticals Djb Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
Figure 2: Global: Intravenous Ibuprofen Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2021
Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2021
Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2021
Figure 7: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2021
Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: North America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: United States: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Canada: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: China: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Japan: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: India: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Australia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Europe: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Germany: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: France: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Italy: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Spain: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Russia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2021
Figure 72: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Global: Intravenous Ibuprofen Industry: SWOT Analysis
Figure 74: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
Figure 75: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis